### Approval answers only one part of the question
An equipment demonstration often has a clear centre of attention: the person who can authorise the purchase. That is understandable. The supplier needs to explain the proposition, the purchaser needs to assess its value and both need to understand the commercial commitment. The problem begins when the approval obtained in that setting is allowed to stand for every other kind of product evidence. The person who signs may not load the equipment, maintain the processing account or explain its output to another buyer. Those responsibilities do not become less consequential because they sit outside the buying meeting.
I made that mistake in 2017 when I approved a tray-handling design after a purchaser-led demonstration. Later review involved eighteen operators. Eleven needed another person for the proposed handling routine; seven did not report that difficulty. The figures did not establish an injury rate or a universal judgement about safe use. They showed that the product decision had not adequately considered a routine expected of another group. Ruth's challenge was direct: why had the people doing the work entered our inquiry after the people approving the expenditure? I could not answer by pointing to the success of the demonstration.
The commercial objection to reopening the design was reasonable. Customers had seen the cabinet, delivery expectations existed and further work would cost time and money. A product team cannot treat every new observation as though earlier commitments have no consequence. But neither can it use those commitments to make an omitted question disappear. We spent ₹68 lakh on the correction, including ₹19 lakh customer credits, and investigated a smaller-tray prototype through the appropriate engineering and usability review. The expense belonged in the account alongside the design response. My original approval also remained part of the explanation.
The lesson was not that purchasers are poor research participants. They can explain investment priorities, constraints and the reasons a proposition may be worth considering. Their evidence matters. It simply does not exhaust the evidence needed for the product decision. The research plan should identify who performs the relevant work and who depends on its result, then ask what each can meaningfully establish. An operator cannot necessarily authorise the investment, and a purchaser cannot necessarily describe the operator's routine. Product leadership has to connect those perspectives rather than allow the most commercially convenient one to absorb the others.
### Different participants supply different evidence
Our 2023 research made that distinction more explicit. Forty-five interviews comprised fifteen purchaser-sponsors, fifteen operators and fifteen produce buyers. These were not forty-five equivalent customers casting votes for features. Sponsors wanted a remote view of progress. Operators wanted a clearer batch-record handoff. Produce buyers wanted documentation relevant to accepting output. The requests concerned different responsibilities. Combining them into a single popularity ranking would have made the analysis look simple while obscuring why each participant wanted the feature and what decision the feature could actually support.
The remote view had a persuasive commercial case. It would be visible during demonstrations and could help a purchaser explain the investment internally. The operator handoff was less dramatic in a sales conversation, but it concerned the account passing through the processing work. Produce buyers' documentation needs introduced another boundary: a new feature would not itself create quality acceptance or a purchase contract. We needed to understand how the requests related to one another before deciding their development order. Counting them could organise the research, but it could not supply the product judgement by itself.
I supported a ₹2.6 crore programme prioritising the batch-record handoff and deferred the sponsor-facing remote view for six months. That choice did not prove the sponsor's request was unnecessary. It selected a sequence while retaining the deferred need. Nor did the handoff become a quality certificate simply because a produce buyer might value a clearer account. Qualified customer quality owners continued to determine what evidence was relevant to their output. The product programme addressed a defined part of the work and left the surrounding responsibilities visible rather than presenting the feature as a complete answer.
This is where research can become uncomfortable for a product leader. Several participants may be right about what they need, while the organisation cannot build everything at once. The temptation is to describe the selected feature as the research winner and let that language silence the rest. I prefer to state whose work it serves first, why that sequence was chosen and what the choice postpones. The decision can then be challenged on its actual reasoning. A count of interviews should not become a shield against explaining how the product team moved from observations to a commitment.
### Choose the sequence without erasing the other needs
A useful research account begins with relationships rather than a generic category called user. Who approves the expenditure? Who performs the routine? Who accepts or rejects the output? Who carries a responsibility the equipment cannot transfer? The answers differ by product and customer setting. They should guide recruitment and interpretation without becoming a rigid template that assumes every enterprise contains the same roles. Sometimes one person carries several responsibilities. Even then, the questions remain distinct, and a favourable answer about one part of the proposition should not quietly settle the others.
The product account also needs to distinguish experience from professional approval. Operator research can reveal a difficulty that warrants redesign or further assessment. It does not automatically certify a solution. Engineering, processing and quality owners must examine the relevant conditions through their proper work. My tray correction did not establish energy savings or food suitability. It changed the design inquiry and the evidence required before a defined release. That boundary matters because a story about listening to users can become another expansive claim if the resulting product is described as universally suitable without the supporting assessment.
For an executive team, the research should clarify the consequence of the chosen sequence. In the handoff programme, the sponsor view arrived later and the demonstration remained less complete in that respect. We did not erase that sacrifice by claiming a measured income or quality improvement that had not been established. The question was whether the selected development improved the intended product relationship sufficiently to justify its expense and timing. Commercial colleagues could still challenge that judgement. Their involvement should sharpen the account rather than require every decision to end with a story in which all stakeholder needs were satisfied at once.
I now regard the buying meeting as one important point in a larger product relationship. It tells us something about the willingness and authority to commit. The work following purchase tells us whether the proposition fits the routines and decisions on which that commitment depends. A product leader should make both available to examination. My own error showed how easily a convincing demonstration can narrow that inquiry. The remedy is not a ritual invitation for operators after the main decision is effectively made. It is a research and development account in which their responsibilities help shape what the organisation is prepared to call finished.